Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry
Results 301 - 320 out of 500 displayed.
« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 »
Reset ↻

Altamira Therapeutics Announces Publication of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis in Top Peer Reviewed Journal

Read more ››

By: GlobeNewswire - 24 Apr 2024

Related companies: Altamira Therapeutics Ltd.

Novo Nordisk A/S – Reduction of the share capital

Read more ››

By: GlobeNewswire - 24 Apr 2024

Novo Nordisk A/S - Articles of Association, April 2024

Read more ››

By: GlobeNewswire - 24 Apr 2024

Autonomix to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar

Read more ››

By: GlobeNewswire - 24 Apr 2024

Related companies: Autonomix Medical, Inc.

T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024

Read more ››

By: GlobeNewswire - 24 Apr 2024

Related companies: T2 Biosystems, Inc.

Verana Health Announces Launch of Qdata® Thyroid Eye Disease

Read more ››

By: GlobeNewswire - 24 Apr 2024

Related companies: Verana Health, Inc.

RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership

Read more ››

By: GlobeNewswire - 24 Apr 2024

Related companies: Renovaro Inc.

Sharecare awarded three-year NCQA Accreditation for Case Management

Read more ››

By: GlobeNewswire - 24 Apr 2024

Related companies: Sharecare, Inc.

HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG

Read more ››

By: GlobeNewswire - 24 Apr 2024

Related companies: HeartSciences Inc.

Capricor Therapeutics Announces Positive Type-B Meeting with FDA for CAP-1002 Program for Duchenne Muscular Dystrophy

Read more ››

By: GlobeNewswire - 24 Apr 2024

Related companies: Capricor Therapeutics, Inc.

Eko2o S.A.S., a Majority-Controlled Subsidiary of MedCana/SFWJ Advances as Leading Infrastructure Supplier for Colombia’s Top Flower Producers

Read more ››

By: GlobeNewswire - 24 Apr 2024

Spectral AI Names Erich Spangenberg CEO of its IP Focused Subsidiary and Explores Potential Spin-Off of that Subsidiary

Read more ››

By: GlobeNewswire - 24 Apr 2024

Related companies: Spectral AI, Inc.

CG Oncology to Unveil Encouraging Results on Cretostimogene in Combination with Pembrolizumab at ASCO 2024

Read more ››

By: GlobeNewswire - 24 Apr 2024

Related companies: CG Oncology, Inc.

ALX Oncology Announces Two Evorpacept Abstracts Accepted for Poster Presentation at 2024 ASCO Annual Meeting

Read more ››

By: GlobeNewswire - 24 Apr 2024

Related companies: ALX Oncology, Inc.

Immunocore announces upcoming presentation and posters at ASCO 2024

Read more ››

By: GlobeNewswire - 24 Apr 2024

Related companies: Immunocore Limited

ImPact Biotech to Present Interim Phase 3 Data from ENLIGHTED Study of Padeliporfin VTP in Low Grade UTUC at Upcoming Medical Conferences

Read more ››

By: GlobeNewswire - 24 Apr 2024

Related companies: Impact Biotech, LLC

Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Read more ››

By: GlobeNewswire - 24 Apr 2024

Related companies: Cue Biopharma, Inc.

Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Read more ››

By: GlobeNewswire - 24 Apr 2024

Related companies: Coherus BioSciences, Inc.

Werewolf Therapeutics Announces WTX-124 Clinical Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

Read more ››

By: GlobeNewswire - 24 Apr 2024

Related companies: Werewolf Therapeutics, Inc.

Medicenna Announces Oral Presentation of MDNA11 Data from the Phase 1/2 ABILITY-1 Study at the 2024 ASCO Annual Meeting

Read more ››

By: GlobeNewswire - 24 Apr 2024

Related companies: Medicenna Therapeutics Corp.

« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 »

to the top ↑